India's food regulator sends notices to Nestle India and Zydus Wellness over claims
India's FSSAI has demanded scientific evidence for marketing claims on Nestle India and Zydus Wellness products, deeming some non-compliant.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
India's Food Safety and Standards Authority (FSSAI) has issued notices to Zydus Wellness and Nestle India over allegedly misleading claims about their products, according to a post on the regulator's social media, as reported by Moody's and Mint. The regulator wants scientific backing for the statements. For Zydus, the notice concerns advertising for Complan, including phrases about supporting concentration and memory and "2x Faster Growth." Nestle India received notices for Lactogen Pro 1 Powder and Nan Excella Pro Stage 1.
For Nestle, FSSAI also judged an immune-support claim non-compliant and asked the company to explain why action should not be started under the Food Safety and Standards Act, 2006. Zydus said Complan meets all applicable rules and that it had submitted a detailed clarification to authorities.
why it matters
The story mainly concerns consumer goods and infant and nutrition marketing in India. For investors it signals tighter regulatory scrutiny of advertising claims, which could raise compliance and marketing costs for packaged food makers.
market impact
Nestle India and Zydus Wellness: risk of regulatory penalties and higher marketing compliance costs in India.
tags
instruments
sources
- FSSAI issues notices to Zydus Wellness, Nestle India — Moody's, 21 October 2026 at 15:50 UTC
- FSSAI issues notices to Nestle India, Zydus Wellness over product claims — Moody's, 21 October 2026 at 18:35 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗